US Broker Ratings

Azenta, Inc. (AZTA) Stock Analysis: Capturing a Potential 15.79% Upside in the Healthcare Sector

Investors with an eye on the healthcare sector might find Azenta, Inc. (NASDAQ: AZTA) an intriguing prospect, especially given its positioning in the burgeoning field of life sciences. With its..

Investor Outlook: AdaptHealth Corp. (AHCO) Poised for 28.77% Upside with Strong Buy Ratings

AdaptHealth Corp. (NASDAQ: AHCO) is drawing significant attention in the healthcare sector, particularly among investors eyeing the medical devices industry. Headquartered in Plymouth Meeting, Pennsylvania, and founded in 2012, AdaptHealth..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring an 84% Potential Upside in Neurodegenerative Treatment Innovations

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out as a promising player in the biotechnology sector, focusing on groundbreaking treatments for neurodegenerative and lysosomal storage diseases. With a market capitalization of..

Xenon Pharmaceuticals (XENE) Stock Analysis: A 20% Upside Potential Awaits Investors in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology company, is capturing the attention of the investment community with its promising pipeline in the neuroscience domain. The company is currently valued..

Evotec SE (EVO) Stock Analysis: Navigating 87.58% Potential Upside Amidst Challenges

Evotec SE (EVO), a prominent player in the healthcare sector specializing in drug discovery and development, is capturing investor attention with its significant potential upside of 87.58%. This German-based company,..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a 6.16% Potential Upside in CNS Therapeutics

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands at the forefront of biotechnology, with a strategic focus on developing and commercializing medications for central nervous system (CNS) disorders and rare diseases. Headquartered..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Promising Biotech with Significant Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is making waves in the biotechnology sector with its innovative approach to peptide therapeutics. With a focus on hematology, blood disorders, and inflammatory diseases, this..

Supernus Pharmaceuticals, Inc. (SUPN): Analyst Consensus and Growth Prospects Unveiled

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, specifically within the specialized realm of drug manufacturing for central nervous system (CNS) diseases. With a market capitalization..

CONMED Corporation (CNMD) Investor Outlook: Assessing a 20.88% Potential Upside in the Medical Devices Sector

CONMED Corporation (NYSE: CNMD), a prominent player in the healthcare sector, particularly in the medical devices industry, is capturing investor attention with a potential upside of 20.88% based on the..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Potential Upside with a 26.41% Gain Insight

Teladoc Health, Inc. (NYSE: TDOC), a prominent player in the virtual healthcare industry, is capturing investor attention with a potential upside of 26.41%. As a leading provider of telehealth services,..

National HealthCare Corporation (NHC): Evaluating Growth Potential Amidst Record Highs

With a robust market presence and a diverse range of healthcare services, National HealthCare Corporation (NYSE: NHC) stands as a noteworthy entity in the medical care facilities industry. Boasting a..

Schrodinger, Inc. (SDGR) Stock Analysis: Unpacking a 40% Potential Upside in Health Information Services

For investors seeking exposure in the healthcare sector, Schrodinger, Inc. (NASDAQ: SDGR) offers an intriguing opportunity. With a market capitalization of $1.43 billion, this New York-based company is a leader..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare’s Complexities with a 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC) operates within the intricate landscape of healthcare improvement services, catering to a network of hospitals, health systems, and other healthcare providers. Based in Charlotte, North Carolina,..

Bausch Health Companies Inc. (BHC) Stock Analysis: Unpacking the 4.23% Upside Potential in the Healthcare Sector

Bausch Health Companies Inc. (NYSE: BHC), a prominent name in the healthcare sector, is gaining attention from investors with its potential upside of 4.23%. Specializing in specialty and generic drug..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A 362% Potential Upside Beckons Investors

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning player in the biotechnology sector, is attracting considerable attention from investors with its promising potential upside of 362.16%. Specializing in the development of..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 39.74% Potential Upside for This Biotech Innovator

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company headquartered in Brisbane, California, is drawing investor attention with its focus on transformative treatments for serious immunological diseases. With a current..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Unpacking a 24% Upside Potential in Biotech

Apogee Therapeutics, Inc. (APGE) is catching the eye of investors amid its promising position in the biotechnology sector. With a current market cap of $5.33 billion, this clinical-stage company is..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring the 22.67% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. Headquartered in Burlington, Massachusetts, this company has carved..

Tarsus Pharmaceuticals, Inc. (TARS): Investor Outlook on a Biotech Powerhouse with 146.7% Revenue Growth

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has caught the attention of investors with its dynamic approach to biopharmaceutical innovation, particularly within eye care. As a player in the biotechnology industry, Tarsus..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 22.97% Potential Upside in Biotech

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company based in Morrisville, North Carolina, has been gaining attention in the healthcare sector due to its innovative approach to treating pulmonary diseases. Specializing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds